Picture of Guardant Health logo

GH Guardant Health Income Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapNeutral

Annual income statement for Guardant Health, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue214287374450564
Cost of Revenue
Gross Profit144194251294337
Selling / General / Administrative Expenses
Research And Development
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses2975427609991,165
Operating Profit-82.4-255-386-550-601
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes-69.7-246-384-653-479
Provision for Income Taxes
Net Income After Taxes-67.9-246-385-655-479
Minority Interest
Net Income Before Extraordinary Items
Extraordinary Items
Net Income-75.7-254-406-655-479
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income-75.7-254-406-655-479
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS-0.835-2.54-4.16-6.37-4.07